| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 4.26% | 128.48% | 317.65% | 70/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 1.02% | 108.06% | 368.42% | 95/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -0.38% | 95.1% | 98.26% | 116/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -21.83% | 36.52% | -45.92% | 135/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -14.96% | -15.08% | -18.26% | 141/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -12.65% | 33.46% | -63.23% | 143/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -7.75% | 6.63% | 77.46% | 139/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -34.39% | 12.6% | -164.54% | 139/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -13% | 54.48% | 31.61% | 134/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -19.01% | -7.52% | -129.04% | 145/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -8.3% | -12.01% | 78.91% | 141/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -39.35% | 14.16% | -37.78% | 143/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -28.56% | -16.81% | -61.54% | 137/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -17.68% | -71.82% | -138.6% | 142/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -7.41% | 2% | 83.84% | 132/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -45.84% | 17.21% | -87.48% | 142/158 | 0.79% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | -24.45% | 41.62% | -137.61% | 129/158 | 4.44% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -10.29% | 2% | 81.42% | 135/158 | 2.97% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | -55.37% | 27.03% | -32.21% | 139/158 | 3.66% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-09-30 | -41.88% | 2% | 44.81% | 115/158 | 3.07% | 哈三联 | 27.17% | 行业排名> |
| 2019-12-31 | -75.88% | -39.72% | -39.72% | 131/158 | 2.57% | 汇宇制药 | 55.94% | 行业排名> |
| 2018-12-31 | -54.31% | 2% | 2% | 131/158 | 7.17% | 河化股份 | 45.32% | 行业排名> |

微信公众号
证券之星APP


